Univest Financial (UVSP) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
24 Oct, 2025Executive summary
Net income for Q3 2025 was $25.6 million ($0.89 diluted EPS), up 38% year-over-year, aided by a $967K tax-free BOLI death benefit claim.
Commercial loan commitments rose to $808 million through September 30, but loan outstandings contracted by $41.1 million year-to-date.
Deposits increased by $635.5 million in the quarter, mainly due to a $473.2 million seasonal build in public funds; total deposits rose 9.7% sequentially and 5.3% year-over-year.
Total assets reached $8.57 billion at September 30, 2025, with $5.7 billion in assets under management.
Return on average assets and equity improved to 1.24% and 11.02% for Q3 2025.
Financial highlights
Net interest income for Q3 2025 rose 15.4% year-over-year to $61.7 million, with net interest margin at 3.17% (up from 2.82% a year ago); core NIM (excluding excess liquidity) expanded to 3.33%.
Noninterest income for Q3 2025 was $21.9 million, up 8.8% year-over-year, including a $967K BOLI benefit.
Noninterest expense for Q3 2025 was $50.7 million, up 4.4% year-over-year, mainly due to compensation and other expenses.
Provision for credit losses was $517,000 for Q3 2025; allowance for credit losses held steady at 1.28%.
Net charge-offs for the quarter were $480,000, or 0.03% annualized of average loans and leases.
Outlook and guidance
Loans expected to remain relatively flat for the full year compared to December 31, 2024.
Net interest income projected to grow 12–14% year-over-year.
Provision for credit losses forecasted at $11–13 million for 2025, with event-driven adjustments.
Non-interest income for 2025 expected to grow 1–3% from a base of $84.5 million (excluding one-time items).
Management expects to maintain capital levels above regulatory minimums and capital conservation buffer.
Latest events from Univest Financial
- Annual meeting to vote on directors, auditor, and executive pay, with strong governance and ESG focus.UVSP
Proxy Filing13 Mar 2026 - Q4 2025 net income up 21.5% with record EPS, strong loan growth, and robust share repurchases.UVSP
Q4 20253 Feb 2026 - Q2 net income rose to $18.1M as loan and deposit growth offset margin pressure.UVSP
Q2 20242 Feb 2026 - Q3 net income rose 9.2% to $18.6M, with strong deposit growth and robust capital ratios.UVSP
Q3 202418 Jan 2026 - Q4 net income up 18.2% to $18.9M, with strong loan growth and a positive 2025 outlook.UVSP
Q4 20249 Jan 2026 - Net income up 10.3% to $22.4M, with higher margins, strong capital, and increased dividend.UVSP
Q1 202523 Dec 2025 - April 2025 meeting covers director elections, auditor ratification, and say-on-pay vote.UVSP
Proxy Filing1 Dec 2025 - Earnings rose on higher NIM, despite a large commercial loan charge-off.UVSP
Q2 202516 Nov 2025